CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $671,000 | +114.4% | 13,012 | +2.9% | 0.00% | +200.0% |
| Q2 2022 | $313,000 | -28.2% | 12,643 | -27.2% | 0.00% | 0.0% |
| Q1 2022 | $436,000 | -44.7% | 17,374 | -19.8% | 0.00% | -50.0% |
| Q4 2021 | $788,000 | +110.7% | 21,659 | -0.9% | 0.00% | +100.0% |
| Q3 2021 | $374,000 | +5.4% | 21,853 | -17.7% | 0.00% | 0.0% |
| Q2 2021 | $355,000 | -69.7% | 26,540 | +16.3% | 0.00% | -75.0% |
| Q1 2021 | $1,170,000 | -12.8% | 22,827 | +5.4% | 0.00% | -20.0% |
| Q4 2020 | $1,341,000 | +42.5% | 21,657 | +26.1% | 0.01% | +25.0% |
| Q3 2020 | $941,000 | +2.7% | 17,179 | +7.9% | 0.00% | -20.0% |
| Q2 2020 | $916,000 | +119.1% | 15,928 | +53.1% | 0.01% | +66.7% |
| Q1 2020 | $418,000 | -41.7% | 10,407 | -42.6% | 0.00% | 0.0% |
| Q4 2019 | $717,000 | +419.6% | 18,124 | -11.2% | 0.00% | +200.0% |
| Q3 2019 | $138,000 | -23.3% | 20,407 | +5.6% | 0.00% | 0.0% |
| Q2 2019 | $180,000 | -33.8% | 19,319 | -1.5% | 0.00% | -50.0% |
| Q1 2019 | $272,000 | +27.7% | 19,606 | +0.6% | 0.00% | +100.0% |
| Q4 2018 | $213,000 | -27.6% | 19,495 | -16.3% | 0.00% | -50.0% |
| Q3 2018 | $294,000 | -5.2% | 23,294 | -1.0% | 0.00% | 0.0% |
| Q2 2018 | $310,000 | -11.4% | 23,541 | -8.4% | 0.00% | 0.0% |
| Q1 2018 | $350,000 | +96.6% | 25,705 | -14.1% | 0.00% | +100.0% |
| Q4 2017 | $178,000 | -17.6% | 29,940 | +2.8% | 0.00% | -50.0% |
| Q3 2017 | $216,000 | -14.3% | 29,111 | +8.3% | 0.00% | -33.3% |
| Q2 2017 | $252,000 | +22.9% | 26,884 | -4.5% | 0.00% | +50.0% |
| Q1 2017 | $205,000 | -21.5% | 28,164 | -20.2% | 0.00% | -33.3% |
| Q4 2016 | $261,000 | +33.2% | 35,278 | +8.9% | 0.00% | 0.0% |
| Q3 2016 | $196,000 | +14.6% | 32,397 | -15.1% | 0.00% | +50.0% |
| Q2 2016 | $171,000 | +92.1% | 38,159 | +6.4% | 0.00% | +100.0% |
| Q1 2016 | $89,000 | -72.2% | 35,848 | -9.4% | 0.00% | -75.0% |
| Q4 2015 | $320,000 | +45.5% | 39,562 | +9.0% | 0.00% | +33.3% |
| Q3 2015 | $220,000 | -30.4% | 36,284 | -5.6% | 0.00% | -25.0% |
| Q2 2015 | $316,000 | +3.9% | 38,444 | -4.4% | 0.00% | 0.0% |
| Q1 2015 | $304,000 | +29.4% | 40,202 | +16.7% | 0.00% | +33.3% |
| Q4 2014 | $235,000 | +57.7% | 34,462 | +4.2% | 0.00% | +50.0% |
| Q3 2014 | $149,000 | -35.5% | 33,067 | -16.1% | 0.00% | -33.3% |
| Q2 2014 | $231,000 | -39.7% | 39,427 | -31.7% | 0.00% | -40.0% |
| Q1 2014 | $383,000 | +221.8% | 57,709 | +179.7% | 0.01% | +150.0% |
| Q4 2013 | $119,000 | +38.4% | 20,629 | +32.8% | 0.00% | 0.0% |
| Q3 2013 | $86,000 | – | 15,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |